Albany, NY -- (SBWIRE) -- 03/08/2016 -- A new market research report by Transparency Market Research presents a detailed analysis of the global Alzheimer's drugs market. The research study, titled "Alzheimer's Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 – 2018," talks about the market overview, market drivers and restraints, opportunities and challenges, current market trends, major geographical segments, product segmentation, and vendor analysis of the market. The research study further includes historical data and forecast figures with the help of charts, tables, and infographics along with strategic recommendations to guide the existing as well as new players in formulating their business strategies and policies effectively.

Alzheimer's disease is a progressive neurological disorder that affects the functioning of the brain resulting in neuron loss. The most common symptom in the early stages is a difficulty in remembering, leading to short-term memory loss. At present, the global Alzheimer's market does not offer any definitive treatment in order to cure or prevent Alzheimer's disease. The global market only offers Alzheimer's drugs to inhibit the progression of the condition.

Request for Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1245

Patients having Alzheimer's disease are mostly given neurotransmitters including cholinesterase inhibitors and memantine. These drugs help the patient by slowing the progression of the condition. In addition, they offer temporary relief from several common symptoms of Alzheimer's such as depression, anxiety, insomnia, and agitation in some cases.

The global market for Alzheimer's drugs has been divided on the basis of geography into North America, Asia Pacific, Europe, and Rest of the World. Among these regions, North America dominates the overall market, holding around a share of 50% in the global Alzheimer's drugs market in 2011. This region is estimated to remain in the leading position in the forecast period. India, Russia, Australia, and China are projected to hold growth potential owing to their unmet medical needs.

The increasing geriatric population across the globe is another factor that is expected to augment the growth of the global Alzheimer's drugs market. Thus, it is becoming imperative for market players to launch new drugs and effective treatments. Most of the market players are currently concentrating on several research and development activities that could potentially lead to breakthroughs. In addition, the global market for Alzheimer's drugs will have to struggle with challenges including drug patent expiry.

Furthermore, the vendor analysis of the global Alzheimer's drugs market has been discussed in the research report. The study provides insights into the company through a profile, inception details, product portfolio, financial overview, business policies, and mergers and acquisitions, if any. Some of the major players operating in the global Alzheimer's drugs market are Forest Laboratories, Inc., Novartis AG, Pfizer Incorporated, H. Lundbeck A/S, and Eisai Co., Ltd.

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/